• 3/29/2018
    Over 850 Cases of Various Diseases and Disorders Diagnosed and Treated 
    as a Direct Result of Newborn Screening Program

    Since established in 2003, Qatar’s Newborn Screening Program (QNSP) has enabled the early diagnoses of over 850 babies born with various diseases and disorders. To date, the newborn heel prick test, which is generally administered within 72 hours of a baby’s birth, has been administered to over 265,000 newborns across the country. 

    Dr. Hilal Al Rifai, Director of Qatar’s Newborn Screening Program and Medical Director of the Women’s Wellness and Research Center, said the newborn screening program plays an often lifesaving role in detecting and treating serious illnesses that would otherwise go undiagnosed or have delayed diagnoses. He added that the number of diseases and disorders diagnosed to date demonstrates the importance of parents consenting to the newborn screening.

    “The Newborn Screening Program allows us to start treatment before a disease or disorder progresses.The program, which offers free disease screening for all children born in Qatar, currently screens for more than 30 disorders, most of which are autosomal recessive, meaning both of the baby’s parents are carriers of the gene that causes the disorder. It allows us to detect disorders, including those among babies that may seem healthy at first, before they progress to serious illness. This is significant as many of these newborn babies may initially appear healthy, however, the illnesses can progress very quickly,” said Dr. Al Rifai.

    According to Dr. Ghassan Abdoh, Senior Consultant of Pediatric Neonatology and Head of HMC’s Newborn Screening Unit, which is based at the Women’s Wellness and Research, a disease diagnosis can be overwhelming at any age, but the diagnosis is particularly difficult when the patient is a newborn. He says his team is committed to both educating parents about the importance of the screening test and also about what a positive result would mean for their family.

    “When we suspect a newborn has a disease, we communicate with his or her parents, taking into consideration how difficult it will be for them to hear the diagnosis. It can be an overwhelming experience for many parents because the need for treatment is almost always immediate; there is often no time to address the emotional side of the diagnosis as we often need to move directly to treating the condition. The screening, which quickly identifies specific conditions and disorders that are not apparent at birth, has resulted in over 98 percent of babies diagnosed in Qatar being successfully treated for potentially fatal and disabling conditions,” said Dr. Abdoh.

    Qatar’s Newborn Screening Program is divided into three components; the Newborn Screening Unit, which works with maternity units and primary health care teams to coordinate testing and follow up of results, the specialized laboratory that conducts the testing, and the teams that provide treatment to affected babies, both short- and long-term. 

    Dr. Al Rifai added that the newborn screening program is going beyond diagnosis and treatment and is actively conducting research and introducing the latest evidence-based treatment protocols. He says the program has introduced genomic technology through its partnership with Germany’s University of Heidelberg Hospital, noting that through more advanced technology, it may be possible to identify even more infants for whom early interventions can prevent serious illnesses or disability.